JP2024505923A5 - - Google Patents

Info

Publication number
JP2024505923A5
JP2024505923A5 JP2023546007A JP2023546007A JP2024505923A5 JP 2024505923 A5 JP2024505923 A5 JP 2024505923A5 JP 2023546007 A JP2023546007 A JP 2023546007A JP 2023546007 A JP2023546007 A JP 2023546007A JP 2024505923 A5 JP2024505923 A5 JP 2024505923A5
Authority
JP
Japan
Prior art keywords
baseline
patient
item
composition according
amyloidosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023546007A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024505923A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2022/050785 external-priority patent/WO2022162625A1/en
Publication of JP2024505923A publication Critical patent/JP2024505923A/ja
Publication of JP2024505923A5 publication Critical patent/JP2024505923A5/ja
Pending legal-status Critical Current

Links

JP2023546007A 2021-01-29 2022-01-29 Ａｌアミロイドーシスを処置する方法 Pending JP2024505923A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163143728P 2021-01-29 2021-01-29
US63/143,728 2021-01-29
PCT/IB2022/050785 WO2022162625A1 (en) 2021-01-29 2022-01-29 Methods of treating al amyloidosis

Publications (2)

Publication Number Publication Date
JP2024505923A JP2024505923A (ja) 2024-02-08
JP2024505923A5 true JP2024505923A5 (https=) 2025-02-06

Family

ID=80222587

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023546007A Pending JP2024505923A (ja) 2021-01-29 2022-01-29 Ａｌアミロイドーシスを処置する方法

Country Status (13)

Country Link
US (1) US20250084153A1 (https=)
EP (1) EP4284829A1 (https=)
JP (1) JP2024505923A (https=)
KR (1) KR20230136643A (https=)
CN (1) CN117098775A (https=)
AU (1) AU2022213010A1 (https=)
CA (1) CA3206326A1 (https=)
CL (1) CL2023002236A1 (https=)
IL (1) IL304755A (https=)
JO (1) JOP20230172A1 (https=)
MX (1) MX2023008835A (https=)
TW (1) TW202332465A (https=)
WO (1) WO2022162625A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4582446A3 (en) 2019-03-05 2025-08-13 Prothena Biosciences Limited Methods of treating al amyloidosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2914781T3 (es) * 2016-06-30 2022-06-16 Prothena Biosciences Ltd Composiciones para el tratamiento de la amiloidosis
US11382974B2 (en) * 2017-08-01 2022-07-12 The Trustees Of Columbia University In The City Of New York Methods and compositions for treatment of amyloid deposition diseases
EP4582446A3 (en) * 2019-03-05 2025-08-13 Prothena Biosciences Limited Methods of treating al amyloidosis

Similar Documents

Publication Publication Date Title
US20230159647A1 (en) Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an il-4r inhibitor
JP2022522889A5 (https=)
NO20170737A1 (no) Anvendelse av anti-CD3 antistoff for fremstilling av et medikament mot aterosklerose, samt et anti-CD3 antistoff
JP2022500382A5 (https=)
JP2024505923A5 (https=)
IL323497A (en) Methods for treating eosinophilic gastroenteritis by administering an IL-4R antagonist
JP2022520572A5 (https=)
AU668081B2 (en) Non-depleting CD4-specific monoclonal antibodies for the treatment of insulin-dependent diabetes mellitus (IDDM)
JP2022553378A5 (https=)
US20260062500A1 (en) Bispecific antibody targeting hk2 and cd3 for the treatment of prostate cancer
CN121889423A (zh) 使用抗gfral抗体治疗恶心和呕吐病症的方法
JP2025509892A (ja) 前立腺癌の治療のためのｔ細胞エンゲージ分子を用いた併用療法
HK40022146A (en) Methods for enhancing allergen-specific immunotherapy by administering an il-4r inhibitor
HK1216898B (en) Methods for enhancing allergen-specific immunotherapy by administering an il-4r inhibitor
HK1099525B (en) Methods of treating atherosclerosis